{
  "docId": "019de075-ba14-74ac-bf24-b9a07d855845",
  "docSlug": "ce85efab4cdfea0a9273e6eac7085298",
  "documentTitle": "MindMed | Investor Presentation Deck | 32 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 32,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-ba14-74ac-bf24-b9a07d855845/18",
  "deckHref": "/decks/019de075-ba14-74ac-bf24-b9a07d855845",
  "deckJsonHref": "/decks/019de075-ba14-74ac-bf24-b9a07d855845.json",
  "deckAnchorHref": "/decks/019de075-ba14-74ac-bf24-b9a07d855845#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.68,
        "x": 0.16,
        "y": 0.235
      },
      "kind": "callout",
      "text": "Maximizing MM-120 value through study of various doses and schedules to optimize the drug across indications",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "604c2886-26c5-4b81-ae21-72e27ba1cd3d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.2,
        "y": 0.46
      },
      "kind": "list",
      "text": "Serotonin is a critical and increasingly well-studied target in psychiatry",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2516b800-6edb-472a-955c-4d2fbcc5331d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.2,
        "y": 0.59
      },
      "kind": "list",
      "text": "Creatively exploring innovative treatment paradigms",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be615866-fc8a-418d-8b21-b5fb17a29f64",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.6,
        "x": 0.2,
        "y": 0.68
      },
      "kind": "list",
      "text": "Repeated sub-perceptual doses of MM-120 in ADHD seek to demonstrate proof of principle for both the regimen and at-home delivery.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d13d6aa3-7d79-48d6-866e-c1ba70498bfd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.05,
        "y": 0.09
      },
      "kind": "subtitle",
      "text": "Multi-faceted approach directly targeting the serotonin system",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6dd97a73-1781-470d-a16d-c0631a98c849",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.75,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "Phase 2a Attention-Deficit Hyperactivity Disorder (ADHD)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e8f15098-0477-4e5d-b89a-614a681e733c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}